Legal

a close-up, supportive interaction between two individuals sitting next to each other
Silverado CEO Loren Shook is redefining memory care by blending clinical rigor with radical compassion

he real power is love. It’s love greater than fear,” Loren Shook says.

In a sector heavily defined by compliance and risk mitigation, Loren has built a business around a different premise. For three decades, he has challenged how the senior living industry approaches, delivers, and markets care for people living with memory loss.

Erica Yen
KARL STORZ drives surgical care delivery, with legal guiding risk, governance, and decision-making across markets

In surgical settings, visibility and control shape clinical decisions. Founded in 1945 in Tuttlingen, Germany, KARL STORZ has grown from a two-person business into an international endoscopy and minimally invasive surgery company, now employing over 9,000 people worldwide

Ann Lundy
Ann Lundy guides legal strategy and patient-centered care at West Tennessee Healthcare across regional systems

Healthcare systems face constant pressure from regulations, staffing shortages, rising costs, and emerging technology. Leaders must align care delivery with legal requirements across large regions.

Kim Moses
At Akron Children’s Hospital, pediatric care calls for legal leadership that champions access, compliance, and innovation

Pediatric care has unique pressures. Funding models differ from adult care. Consent can involve several caregivers. Access challenges affect families in ways that don’t always match policy.

Chapter 11 bankruptcy document as financial pressure grows across the healthcare sector in 2026.
Healthcare bankruptcies are rising again as pressure builds

Healthcare bankruptcies are climbing again in 2026 as providers face rising labor costs, reimbursement disputes and refinancing pressure across the sector.

the lobby of Exelixis, Inc., a pharmaceutical company focused on oncology drug discovery and development
General Counsel Brenda Hefti leads legal strategy at Exelixis, launching new oncology treatments and navigating policy challenges

In oncology biotech, legal teams play a central role in advancing scientific innovation within complex regulatory and policy environments. At Exelixis, General Counsel Brenda Hefti, J.D., Ph.D., exemplifies that role by aligning legal strategy with scientific innovation and business objectives. She helps drive the delivery of therapies to patients while guiding the company through litigation, intellectual property strategy, regulatory challenges, and evolving government policy — positioning Exelixis at the critical intersection of law and science.

Roberta Loomar DifGen Pharma
Roberta Loomar is a GC Unafraid of Bringing Decades of Experience to a Rising DifGen

Roberta Loomar challenges herself by taking legal leadership of a company just this side of “startup”